Christopher Brau, R&D process development manager - Thermo Fisher Scientific, explains how continuous perfusion can support small molecule manufacturers and achieve fully intensified biomanufacturing.
Establishing continuous manufacturing (CM) workflows is becoming increasingly popular for intensifying manufacturing processes within the pharmaceutical industry. This is particularly true for small molecule drug manufacturing, following the successful regulatory approval of several CM processes. However, for biopharmaceutical manufacturers, implementation of CM is more complex.